A sustained release anticancer device.
Sugitachi
A
A
Department of Surgery, Osaka National Hospital, Japan.
Takatsuka
Y
Y
Kido
T
T
Sato
E
E
D000818:Animals; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000473:pathology; D003692:Delayed-Action Preparations; D004317:Doxorubicin / Q000008:administration & dosage* / Q000627:therapeutic use; D005176:Factor XIII; D005780:Gelatin; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000473:pathology; D011817:Rabbits; D012044:Regression Analysis; D013917:Thrombin
D003692:Delayed-Action Preparations; D004317:Doxorubicin; D005780:Gelatin; D005176:Factor XIII; D013917:Thrombin